US 11,229,707 B2Granted

Promoting immune responses

AssigneeNational Institute of Biological Sciences

InventorsFeng Shao, Ping Zhou, Yang She, Huabin He, Peng Li, Jingjin Ding, Wenqing Gao

Life of this patent

Estimating the term…

Abstract

Pharmaceutical compositions comprise a 1-ADP-heptose conjugate and may include an immunogen or an immune checkpoint inhibitor, and are used to promote an immune response.

Claims16

Dependent claims

A method of promoting an Alpk1-dependent immune response comprising:

administering to a person in need thereof a composition comprising a 1-ADP-heptose conjugate that is a 1-ADP-heptose-7-phosphate.

Dependencies are inferred from the claim text.

Facts

Application: 17/022,073Filed 15 Sep 2020 · continuation
Priority: WO PCT/CN2018/09117714 Jun 2018
Published: US 2020/0405869 A131 Dec 2020
Granted: 25 Jan 2022
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 39/3955
Against materials from animals: against proteinaceous materials, e.g. enzymes, hormones, lymphokines
A61K 47/549
The modifying agent being an organic compound: sugars, nucleosides, nucleotides or nucleic acids
A61K 31/7076
Containing condensed or non-condensed pyrimidines: containing purines, e.g. adenosine, adenylic acid
A61K 47/55
The modifying agent being an organic compound: the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire…

Family

PCT/CN2019/090647Parent of this continuation · filed 11 Jun 2019
US 2020/0405869 A1Pre-grant publication · published 31 Dec 2020
US 11,229,707 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results